Retraction
MiR-137 functions as a tumor suppressor in pancreatic cancer by targeting MRGBP
Paper Information
Record ID:
52978
Author(s):
Journal:
Publication Date:
January 13, 2018
Retraction Date:
April 01, 2024
(1.6 year years ago)
Subjects:
Institutions:
- Department of Gastroenterology/Hepatology, Zhong Nan Hospital of Wuhan University, Wuhan, China
- The Hubei Clinical Center & Key Laboratory of Intestinal & Colorectal Diseases, Wuhan, China
- Laboratory of Clinical Immunology, Wuhan No.1 Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
- Department of Pathology, Hubei Cancer Hospital, Wuhan, China
- Department of Gastroenterology, Renmin Hospital of Wuhan University, Wuhan,China
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Wiley
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (29)
29
Total Citations1
Post-Retraction(3.4%)
28
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
1
Within 1 year
0
After 2+ years
144
Days since retraction (latest)
miR-137: a potential therapeutic target for lung cancer
Shuanshuan Liu, Yanyun Ruan, Xu Chen et al. (5 authors)
Frontiers in Cell and Developmental Biology
Open Access
Published: Aug 2024
4 citations
4 citations
144 days after retraction
Development and validation of a chromatin regulator signature for predicting prognosis hepatocellular carcinoma patient
Jiazhen Mao, Fei Song, Yu Zhang et al. (9 authors)
Journal of Gastrointestinal Oncology
Open Access
Published: Feb 2024
2 citations
2 citations
60 days before retraction
Natural products and the balancing act of autophagy-dependent/independent ferroptosis in cancer therapy
Shiva Rahimipour Anaraki, Payam Farzami, Seyed Soheil Hosseini Nasab et al. (11 authors)
Naunyn-Schmiedeberg s Archives of Pharmacology
Published: Oct 2023
5 citations
5 citations
159 days before retraction
A feedback loop between lncRNA MALAT1 and DNMT1 promotes triple-negative breast cancer stemness and tumorigenesis
Yu Hu, Yuqiong He, Na Luo et al. (6 authors)
Cancer Biology & Therapy
Open Access
Published: Aug 2023
6 citations
6 citations
238 days before retraction
miR‑137 is a diagnostic tumor‑suppressive miRNA that targets SPHK2 to promote M1‑type tumor‑associated macrophage polarization.
Jing Liu, Yanwen Xu, Han Tang et al. (11 authors)
PubMed
Published: Aug 2023
2 citations
2 citations
244 days before retraction
MicroRNA-137 Inhibits Esophageal Squamous Cell Carcinoma by Downregulating DAAM1
Weina Li, Xiangdong Bai, Ruyuan Guo et al. (6 authors)
Protein and Peptide Letters
Published: Aug 2022
3 citations
3 citations
590 days before retraction
MRGBP: A New Factor for Diagnosis and Prediction of Head and Neck Squamous Cell Carcinoma
Cheng Zhao, Chuang Wei, Xiatian Chen et al. (4 authors)
BioMed Research International
Open Access
Published: Jul 2022
3 citations
3 citations
616 days before retraction
COL5A1 Promotes the Progression of Gastric Cancer by Acting as a ceRNA of miR-137-3p to Upregulate FSTL1 Expression
Ming Yang, Zhixing Lu, Bowen Yu et al. (17 authors)
Cancers
Open Access
Published: Jul 2022
14 citations
14 citations
640 days before retraction
Functional Screen for microRNAs Suppressing Anchorage-Independent Growth in Human Cervical Cancer Cells
Angelina Huseinovic, Annelieke Jaspers, Annina P. van Splunter et al. (10 authors)
International Journal of Molecular Sciences
Open Access
Published: Apr 2022
6 citations
6 citations
706 days before retraction
Prognostic Value of miR-137 in Children with Medulloblastoma and its Regulatory Effect on Tumor Progression
Wenyuan Ji, Zhe Xuan, Lusheng Li et al. (8 authors)
NeuroMolecular Medicine
Published: Aug 2021
3 citations
3 citations
957 days before retraction
MiR-137 inhibits cervical cancer progression via down-modulating Notch1 and inhibiting the PI3K/AKT/mTOR signaling pathway
Ying Gui, Lina Wang, Zhihong Huang
Translational Cancer Research
Open Access
Published: Aug 2021
7 citations
7 citations
974 days before retraction
MiR-137 inhibits the proliferation, invasion and migration of glioma via targeting to regulate EZH2
Jingshun Gu, Juntong Wang, Aiwu You et al. (10 authors)
Genes & Genomics
Published: Jun 2021
9 citations
9 citations
1013 days before retraction
MRGBP is a potential novel prognostic biomarker and is correlated with immune infiltrates in hepatocellular carcinoma
Juanjun Huang, Xiaoli Chen, Wei Zhu
Medicine
Open Access
Published: Mar 2021
1 citation
1 citation
1105 days before retraction
CTCF-silenced miR-137 contributes to EMT and radioresistance in esophageal squamous cell carcinoma
Shuwen Xu, Xiaofeng Li, Longfei Li et al. (11 authors)
Cancer Cell International
Open Access
Published: Mar 2021
12 citations
12 citations
1120 days before retraction
Hypoxia-Induced miR-137 Inhibition Increased Glioblastoma Multiforme Growth and Chemoresistance Through LRP6
Dongmei Li, Qiudan Chen, Guining Wei et al. (8 authors)
Frontiers in Oncology
Open Access
Published: Feb 2021
30 citations
30 citations
1131 days before retraction
The long non-coding RNA NNT-AS1 promotes clear cell renal cell carcinoma progression via regulation of the miR-137/ Y-box binding protein 1 axis
Yadi Zhou, Zhenghao Zhang, Mingyi Wo et al. (4 authors)
Bioengineered
Open Access
Published: Jan 2021
10 citations
10 citations
1186 days before retraction
LncRNA XIST/miR-137 axis strengthens chemo-resistance and glycolysis of colorectal cancer cells by hindering transformation from PKM2 to PKM1
Hailun Zheng, Mei Zhang, Xiquan Ke et al. (9 authors)
Cancer Biomarkers
Published: Dec 2020
34 citations
34 citations
1189 days before retraction
Identifying Key Genes for Nasopharyngeal Carcinoma by Prioritized Consensus Differentially Expressed Genes Caused by Aberrant Methylation
Yunqin Chen, Chun Zhou, Hua‐Bin Li et al. (5 authors)
Journal of Cancer
Open Access
Published: Dec 2020
19 citations
19 citations
1202 days before retraction
Prognostic value of microRNAs in pancreatic cancer: a meta-analysis
Fei Zhao, Chao Wei, Mengying Cui et al. (6 authors)
Aging
Open Access
Published: May 2020
29 citations
29 citations
1414 days before retraction
MicroRNA‑137 regulates hypoxia‑mediated migration and epithelial‑mesenchymal transition in prostate cancer by targeting LGR4 via the EGFR/ERK signaling pathway
Hao Zhang, Fang Liang, Junmin Yue et al. (11 authors)
International Journal of Oncology
Open Access
Published: May 2020
19 citations
19 citations
1418 days before retraction
Long Noncoding RNA SCAMP1 Targets miR-137/CXCL12 Axis to Boost Cell Invasion and Angiogenesis in Ovarian Cancer
Ran Song, Zhihui Liu, Lijuan Lu et al. (5 authors)
DNA and Cell Biology
Published: May 2020
22 citations
22 citations
1419 days before retraction
miR-137 alleviates doxorubicin resistance in breast cancer through inhibition of epithelial-mesenchymal transition by targeting DUSP4
Feiya Du, Ling Yu, Ying Wu et al. (11 authors)
Cell Death and Disease
Open Access
Published: Dec 2019
62 citations
62 citations
1580 days before retraction
The Regulatory Roles of Non-coding RNAs in Angiogenesis and Neovascularization From an Epigenetic Perspective
Itzel Alejandra Hernández-Romero, Lissania Guerra-Calderas, Marisol Salgado-Albarrán et al. (5 authors)
Frontiers in Oncology
Open Access
Published: Oct 2019
41 citations
41 citations
1621 days before retraction
Downregulation of circular RNA circ-LDLRAD3 suppresses pancreatic cancer progression through miR-137-3p/PTN axis
Jun Yao, Ce Zhang, Yanfei Chen et al. (4 authors)
Life Sciences
Published: Sep 2019
63 citations
63 citations
1663 days before retraction
Propofol suppresses proliferation, invasion, and migration of human melanoma cells via regulating microRNA‐137 and fibroblast growth factor 9
Hong Yu, Meina Ma, Xupeng Wang et al. (6 authors)
Journal of Cellular Physiology
Published: May 2019
10 citations
10 citations
1771 days before retraction
MicroRNA-137 inhibits autophagy and chemosensitizes pancreatic cancer cells by targeting ATG5
Zhichao Wang, Feizhou Huang, Hongbo Xu et al. (5 authors)
The International Journal of Biochemistry & Cell Biology
Published: Jan 2019
70 citations
70 citations
1888 days before retraction
miR-137 functions as a tumor suppressor gene in pituitary adenoma by targeting AKT2.
Jian Duan, Guohui Lu, Youping Li et al. (6 authors)
PubMed
Published: Jan 2019
16 citations
16 citations
1917 days before retraction
miRNA and Gene Expression in Pancreatic Ductal Adenocarcinoma
Anteneh Tesfaye, Asfar S. Azmi, Philip A. Philip
American Journal Of Pathology
Open Access
Published: Dec 2018
58 citations
58 citations
1935 days before retraction
Hypoxia and Selective Autophagy in Cancer Development and Therapy
Ioanna Daskalaki, Ilias Gkikas, Nektarios Tavernarakis
Frontiers in Cell and Developmental Biology
Open Access
Published: Sep 2018
154 citations
154 citations
2030 days before retraction
Quick Stats
Total Citations:
29
Years Since Retraction:
1.6 year
Open Access:
Yes
Last Checked:
Jul 24, 2025